Abstract:Ploidy changes are frequent in nature and contribute to evolution, functional specialization and tumorigenesis (1,2). Analysis of model organisms of different ploidies revealed that increased ploidy leads to an increase in cell and nuclear volume, reduced proliferation (2-4), metabolic changes (5), lower fitness (6,7), and increased genomic instability (8,9), but the underlying mechanisms remain poorly understood. To investigate how the gene expression changes with cellular ploidy, we analyzed isogenic series … Show more
“…Expression and phosphorylation of G2/M, DNA-associated and biosynthetic peptides exhibited a clear sub-scaling relationship with cell size across two independent panels of melanoma cell lines, whilst expression of lipid metabolic genes and phosphorylation of cytoskeletal regulators showed the reverse. This is in strong agreement with numerous recent studies investigating the relationships between cell size and gene/peptide expression; identifying histones as sub-scaling components (Amodeo et al, 2015), observing an upregulation of lipid metabolism in larger cell lines (Neurohr et al, 2019), noting a decreased abundance of translational components and translation rate in large polyploid cells (Yahya et al, 2021) and a full proteome survey of scaling components in human lung fibroblasts (Lanz et al, 2021).…”
Section: Discussionsupporting
confidence: 90%
“…Many proteins have been shown to ‘super’ or ‘sub’ scale (mass fraction increases/decreases) with cell size (Amodeo et al, 2015; Lanz et al, 2021) beyond a small set of proliferative regulators. Indeed, recent studies point to histones (Amodeo et al, 2015; Swaffer et al, 2021), translational components (Yahya et al, 2021) and several metabolic elements (Lanz et al, 2021; Neurohr et al, 2019) sub/super scaling with cell size. Not all these proteins will act as size ‘rulers’, and may instead influence their activity.…”
Almost all living cells maintain size uniformity through successive divisions. Proteins that sub- or super-scale with size act as rheostats which regulate cell progression. A comprehensive atlas of these proteins is lacking; particularly in cancer cells where both mitogen and growth signalling are dysregulated.Utilising a multi-omic strategy, that integrates quantitative single cell imaging, phosphoproteomic and transcriptomic datasets, we leverage the inherent size heterogeneity of melanoma cells to investigate how peptides, post-translational modifications, and mRNAs scale with cell size to regulate proliferation. We find melanoma cells have different mean sizes, but all retain uniformity. Across the proteome, we identify proteins and phosphorylation events that ‘sub’ and ‘super’ scale with cell size. In particular, G2/M, biosynthetic, and cytoskeletal regulators sub- and super-scale with size. In small cells growth and proliferation processes are tightly coupled by translation which promotes CCND1 accumulation and anabolic increases in mass. Counter intuitively, anabolic growth pathways and translational process are low in large cells, which throttles the expression of factors such as CCND1 and thereby coupling proliferation from anabolic growth. Strikingly, these cells exhibit increased growth and comparable proliferation rates. Mathematical modelling suggests that decoupling growth and proliferative signalling fosters proliferation under mitogenic inhibition. As factors which promote adhesion and actin reorganization super-scale with size or are enriched in large cells, we suggest that growth/proliferation in these cells may be decoupled by cell spreading and mechanics. This study provides one of the first demonstrations of size-scaling phenomena in cancer and how morphology determines the chemistry of the cell.
“…Expression and phosphorylation of G2/M, DNA-associated and biosynthetic peptides exhibited a clear sub-scaling relationship with cell size across two independent panels of melanoma cell lines, whilst expression of lipid metabolic genes and phosphorylation of cytoskeletal regulators showed the reverse. This is in strong agreement with numerous recent studies investigating the relationships between cell size and gene/peptide expression; identifying histones as sub-scaling components (Amodeo et al, 2015), observing an upregulation of lipid metabolism in larger cell lines (Neurohr et al, 2019), noting a decreased abundance of translational components and translation rate in large polyploid cells (Yahya et al, 2021) and a full proteome survey of scaling components in human lung fibroblasts (Lanz et al, 2021).…”
Section: Discussionsupporting
confidence: 90%
“…Many proteins have been shown to ‘super’ or ‘sub’ scale (mass fraction increases/decreases) with cell size (Amodeo et al, 2015; Lanz et al, 2021) beyond a small set of proliferative regulators. Indeed, recent studies point to histones (Amodeo et al, 2015; Swaffer et al, 2021), translational components (Yahya et al, 2021) and several metabolic elements (Lanz et al, 2021; Neurohr et al, 2019) sub/super scaling with cell size. Not all these proteins will act as size ‘rulers’, and may instead influence their activity.…”
Almost all living cells maintain size uniformity through successive divisions. Proteins that sub- or super-scale with size act as rheostats which regulate cell progression. A comprehensive atlas of these proteins is lacking; particularly in cancer cells where both mitogen and growth signalling are dysregulated.Utilising a multi-omic strategy, that integrates quantitative single cell imaging, phosphoproteomic and transcriptomic datasets, we leverage the inherent size heterogeneity of melanoma cells to investigate how peptides, post-translational modifications, and mRNAs scale with cell size to regulate proliferation. We find melanoma cells have different mean sizes, but all retain uniformity. Across the proteome, we identify proteins and phosphorylation events that ‘sub’ and ‘super’ scale with cell size. In particular, G2/M, biosynthetic, and cytoskeletal regulators sub- and super-scale with size. In small cells growth and proliferation processes are tightly coupled by translation which promotes CCND1 accumulation and anabolic increases in mass. Counter intuitively, anabolic growth pathways and translational process are low in large cells, which throttles the expression of factors such as CCND1 and thereby coupling proliferation from anabolic growth. Strikingly, these cells exhibit increased growth and comparable proliferation rates. Mathematical modelling suggests that decoupling growth and proliferative signalling fosters proliferation under mitogenic inhibition. As factors which promote adhesion and actin reorganization super-scale with size or are enriched in large cells, we suggest that growth/proliferation in these cells may be decoupled by cell spreading and mechanics. This study provides one of the first demonstrations of size-scaling phenomena in cancer and how morphology determines the chemistry of the cell.
“…Standard RNA-seq only measures relative gene expression, but it is possible to use RNA-seq to estimate changes in absolute expression levels per cell by quantifying the number of cells used in RNA extractions and applying spike-in controls during the sequencing process (63, 64). Given the increased cell size in polyploids, total transcriptome and proteome sizes are expected to scale allometrically with ploidy (65, 66), but how these scaling relationships affect many key features of cytonuclear interactions have yet to be explored in polyploid plants.…”
Mitochondrial and plastid functions depend on coordinated expression of proteins encoded by genomic compartments that have radical differences in copy number of organellar and nuclear genomes. In polyploids, doubling of the nuclear genome may add challenges to maintaining balanced expression of proteins involved in cytonuclear interactions. Here, we use ribo-depleted RNA-seq to analyze transcript abundance for nuclear and organellar genomes in leaf tissue from four different polyploid angiosperms and their close diploid relatives. We find that, even though plastid genomes contain <1% of the number of genes in the nuclear genome, they generate the majority (69.9 - 82.3%) of mRNA transcripts in the cell. Mitochondrial genes are responsible for a much smaller percentage (1.3 - 3.7%) of the leaf mRNA pool but still produce much higher transcript abundances per gene compared to nuclear genome. Nuclear genes encoding proteins that functionally interact with mitochondrial or plastid gene products exhibit mRNA expression levels that are consistently more than ten-fold lower than their organellar counterparts, indicating an extreme cytonuclear imbalance at the RNA level despite the predominance of equimolar interactions at the protein level. Nevertheless, interacting nuclear and organellar genes show strongly correlated transcript abundances across functional categories, suggesting that the observed mRNA stoichiometric imbalance does not preclude coordination of cytonuclear expression. Finally, we show that nuclear genome doubling does not alter the cytonuclear expression ratios observed in diploid relatives in consistent or systematic ways, indicating that successful polyploid plants are able to compensate for cytonuclear perturbations associated with nuclear genome doubling.
“…The increase in the relative proportion of diploids in dgk1 Δ cultures over time suggested an intriguing possibility that S. pombe diploids are less sensitive to the loss of Dgk1 activity than haploids. Such scaling relationships resulting in metabolic and phenotypic differences between cells of different ploidy do exist (Yahya et al, 2021), e.g., S. pombe cells exhibit a more coherent cellular geometry scaling when diploidized (Gu and Oliferenko, 2019).…”
Section: Resultsmentioning
confidence: 99%
“…Although cell size control and homeostasis in haploid S. pombe have been extensively studied, the impact of diploidization on S. pombe physiology and metabolism is less understood. Cell size and ploidy have previously been shown to influence cellular fitness via the cumulative reorganization of the proteome and organelle content (Gu and Oliferenko, 2019; Cheng et al, 2021; Gu and Oliferenko, 2021; Yahya et al, 2021). Changes in metabolism and/or the transmembrane transport efficiency (e.g., due to the decreased surface area-to-volume ratio of diploids), may contribute to different metabolic requirements in diploids.…”
Nuclear envelope (NE) expansion must be controlled to maintain nuclear shape and function. Closed mitosis occurs within an intact NE and thus, requires NE expansion. In the fission yeast S. pombe the expansion is underpinned by CDK1-dependent inactivation of the phosphatidic acid (PA) phosphatase lipin. Yet, how the lipin substrate PA and its product diacylglycerol (DG) are regulated in time and space and what are the implications of changes in their distribution for mitotic fidelity remain unknown. Using genetically encoded PA and DG probes, we show that DG levels drop dramatically at the NE during S. pombe mitosis. We demonstrate that DG-to-PA conversion catalysed by the diacylglycerol kinase Dgk1 is essential to reinforce the drop in DG levels at the NE, in addition to CDK1-dependent lipin inactivation. When DG levels do not decay, NE does not expand causing mitotic failure. Further experiments suggest that DG consumption fuels a spike in glycerophospholipid biosynthesis, controlling NE expansion, and ultimately, mitotic fidelity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.